More Memphasys Ltd news
Memphasys LtdASX: MEM

FELIX System commercialisation, regulatory plan and trial

Oct 23, 2022 at 9:46 PM EDT · Issued by Memphasys Ltd

Filed with ASX · Oct 23, 2022 at 9:46 PM EDT

On 6ix: 6ix.com/news/felix-system-commercialisation-regulatory-plan-and-trial

Memphasys Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Memphasys Ltd on 6ix

Story so far

  • Felix System commercialisation updateJun 9, 2022
  • Follow up sales of FelixTM SystemMar 30, 2022
  • First Felix System commercial sale for clinical IVF useDec 20, 2021

Earlier from Memphasys

  • Rights Issue Closure and Shortfall NotificationSep 19, 2022
  • $3.36 capital raising to accelerate FELIX commercialisationAug 16, 2022
  • Suspension from Official QuotationJul 29, 2022
  • Monash IVF clinical study enrols first patient using FELIXJun 28, 2022
  • Felix System commercialisation updateJun 8, 2022

Later from Memphasys

  • KOL testings demonstrate Felix System outperforms DGCFeb 6, 2023
  • Japan first commercial sale and first baby born using FelixApr 2, 2023
  • Felix considered best method to treat cryopreserved semenJun 5, 2023
  • Vitrolife sign Felix distribution agreement for Japanese mktAug 6, 2023
  • Felix System records 10 new live births in IndiaSep 14, 2023
All Memphasys news releases↗

Follow Memphasys into a list and get an email when it puts out news.

Follow Memphasys
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer